Abiopharma

Jenne Kyle 🟡 adjusted position in 33.7K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.96 Transaction Date: Jan 15, 2026 | Filing ID: 000066

HOUGEN ELIZABETH L 🟡 adjusted position in 34.3K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.22 Transaction Date: Jan 15, 2026 | Filing ID: 000065

Devers Shannon L. 🟡 adjusted position in 27.1K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.95 Transaction Date: Jan 15, 2026 | Filing ID: 000064

Birchler Brian 🟡 adjusted position in 27.0K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.11 Transaction Date: Jan 15, 2026 | Filing ID: 000063

BENNETT C FRANK 🟡 adjusted position in 26.5K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.15 Transaction Date: Jan 15, 2026 | Filing ID: 000062

Baroldi Joseph 🟡 adjusted position in 31.3K shares (5 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $75.78 Transaction Date: Jan 15, 2026 | Filing ID: 000061

Lubner David Charles 🟡 adjusted position in 6.0K shares (1 derivative) of Arcellx, Inc. (ACLX) at $75.00 Transaction Date: Jan 20, 2026 | Filing ID: 017002

Ring Christine 🟡 adjusted position in 3.8K shares (1 derivative) of Nurix Therapeutics, Inc. (NRIX) at $18.42 Transaction Date: Jan 20, 2026 | Filing ID: 000002

New Form SCHEDULE 13G - Nuwellis, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000012 Size: 9 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Synlogic, Inc. - Common Stock. New value: Synlogic, Inc. - Common Stock.

COLUMN GROUP III GP, LP 🟢 acquired 32.5K shares of Surrozen, Inc./DE (SRZN) at $20.00 Transaction Date: Jan 15, 2026 | Filing ID: 016991

Kutzkey Tim 🟢 acquired 32.5K shares of Surrozen, Inc./DE (SRZN) at $20.00 Transaction Date: Jan 15, 2026 | Filing ID: 016980

Heyman Richard A. 🔴 sold 6.7K shares of Oric Pharmaceuticals, Inc. (ORIC) at $12.00 Transaction Date: Jan 16, 2026 | Filing ID: 000006